Laura De Leon

Laura joined PMV in February 2019 as Head of Clinical Operations with nearly two decades of clinical operations experience in the pharmaceutical industry. Laura has worked in multiple therapeutic areas in all phases of development across company type: large pharma, biotech, medical device, and CRO.

Throughout her career, Laura has held positions of increasing responsibility and leadership in clinical operations and program management at PAREXEL International, Thoratec Corporation, CombinatoRx, Inc., Takeda Oncology, Syndax Pharmaceuticals, EMD Serono, and Seres Therapeutics. Prior to joining PMV, Laura was the Director of Clinical Operations at Seres, responsible for the clinical operations strategy, team management, and oversight of study deliverables for two microbiome therapeutic assets in development including the lead product candidate SER-109 in Clostridioides difficile infection. Laura has extensive monitoring and global trial management experience and has been at the forefront of precision medicine in oncology since joining PMV.

Laura holds a BA in Psychology from Boston College and a MS in Health Product Regulation and Health Policy from Regis College.